FastPharming™ Tech


Advantages of Plant Based Protein Production

  • Fast. FastPharming shortens timelines to the clinic and can move a program from gene sequence to protein production in as little as three weeks.
  • Economical. No expensive, labor-intensive, and costly cell line development
  • Quality. Production of consistent therapeutics that are well-accepted by global regulatory bodies
  • Scalable. No time-consuming scale-up challenges
  • Safe. Mammalian viruses can’t grow in plants, so iBio’s plant-based production platform minimizes contamination risks.

    • No animal products or animal-derived components are used at any point in FastPharming.
    • No inherent adventitious agents and no competency for agent replication